دورية أكاديمية

Hyperventilation testing in the diagnosis of vasospastic angina: A clinical review and meta‐analysis.

التفاصيل البيبلوغرافية
العنوان: Hyperventilation testing in the diagnosis of vasospastic angina: A clinical review and meta‐analysis.
المؤلفون: Boivin‐Proulx, Laurie‐Anne, Marquis‐Gravel, Guillaume, Rousseau‐Saine, Nicolas, Harel, François, Jolicoeur, E. Marc, Pelletier‐Galarneau, Matthieu
المصدر: European Journal of Clinical Investigation; Jun2024, Vol. 54 Issue 6, p1-16, 16p
مصطلحات موضوعية: CHEST pain, ANGINA pectoris, HYPERVENTILATION, VENTRICULAR arrhythmia, MYOCARDIAL perfusion imaging, DIAGNOSIS
مستخلص: Background: Given the limited access to invasive vasospastic reactivity testing in Western Countries, there is a need to further develop alternative non‐invasive diagnostic methods for vasospastic angina (VSA). Hyperventilation testing (HVT) is defined as a class IIa recommendation to diagnose VSA by the Japanese Society of Cardiology. Methods: In this systematic review and meta‐analysis reported according to the PRISMA statement, we review the mechanisms, methods, modalities and diagnostic accuracy of non‐invasive HVT for the diagnostic of VSA. Results: A total of 106 articles published between 1980 and 2022 about VSA and HVT were included in the systematic review, among which 16 were included in the meta‐analysis for diagnostic accuracy. Twelve electrocardiogram‐HVT studies including 804 patients showed a pooled sensitivity of 54% (95% confidence intervals [CI]; 30%–76%) and a pooled specificity of 99% (95% CI; 88%–100%). Four transthoracic echocardiography‐HVT studies including 197 patients revealed a pooled sensitivity of 90% (95% CI; 82%–94%) and a pooled specificity of 98% (95% CI; 86%–100%). Six myocardial perfusion imaging‐HVT studies including 112 patients yielded a pooled sensitivity of 95% (95% CI; 63%–100%) and a pooled specificity of 78% (95% CI; 19%–98%). Non‐invasive HVT resulted in a low rate of adverse events, ventricular arrhythmias being the most frequently reported, and were resolved with the administration of nitroglycerin. Conclusions: Non‐invasive HVT offers a safe alternative with high diagnostic accuracy to diagnose VSA in patients with otherwise undiagnosed causes of chest pain. [ABSTRACT FROM AUTHOR]
Copyright of European Journal of Clinical Investigation is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00142972
DOI:10.1111/eci.14178